Academic literature on the topic 'Oral P2Y12 inhibitor'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Oral P2Y12 inhibitor.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Oral P2Y12 inhibitor"
Prüller, Florian, Lukasz Bis, Oliver Milke, Friedrich Fruhwald, Sascha Pätzold, Siegfried Altmanninger-Sock, Jolanta Siller-Matula, et al. "Cangrelor Induces More Potent Platelet Inhibition without Increasing Bleeding in Resuscitated Patients." Journal of Clinical Medicine 7, no. 11 (November 15, 2018): 442. http://dx.doi.org/10.3390/jcm7110442.
Full textAlexopoulos, Dimitrios, Stylianos Dragasis, and Nikolaos Kafkas. "Loading with Oral P2Y12 Receptor Inhibitors: To Crush or Not to Crush?" Thrombosis and Haemostasis 119, no. 07 (May 12, 2019): 1037–47. http://dx.doi.org/10.1055/s-0039-1688790.
Full textStratz, Christian, Thomas Nührenberg, Christian Valina, Nikolaus Löffelhardt, Kambis Mashayekhi, Miroslaw Ferenc, Dietmar Trenk, Franz-Josef Neumann, and Willibald Hochholzer. "Impact of Reticulated Platelets on the Antiplatelet Effect of the Intravenous P2Y12-Receptor Inhibitor Cangrelor." Thrombosis and Haemostasis 118, no. 02 (2018): 362–68. http://dx.doi.org/10.1160/th17-07-0466.
Full textZhou, Xuan, Dominick J. Angiolillo, and Luis Ortega-Paz. "P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention." Journal of Cardiovascular Development and Disease 9, no. 10 (October 6, 2022): 340. http://dx.doi.org/10.3390/jcdd9100340.
Full textDroppa, Michal, Oliver Borst, Dominik Rath, Karin Müller, Meinrad Gawaz, Deepak L. Bhatt, and Tobia Geisler. "Impact of Intravenous P2Y12-Receptor Inhibition with Cangrelor in Patients Presenting with Acute Coronary Syndrome and Cardiogenic Shock – a Case Series." Cellular Physiology and Biochemistry 42, no. 4 (2017): 1336–41. http://dx.doi.org/10.1159/000478962.
Full textMenozzi, Alberto, and Giorgio Caretta. "Acute coronary syndromes with high thrombotic burden: therapeutic innovations." European Heart Journal Supplements 22, Supplement_L (November 1, 2020): L97—L100. http://dx.doi.org/10.1093/eurheartj/suaa144.
Full textJhagroe, Darshni Arishta, and Jurriën Maria ten Berg. "Managing the Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients on Oral Anticoagulation." Interventional Cardiology Review 10, no. 3 (2015): 139. http://dx.doi.org/10.15420/icr.2015.10.03.139.
Full textVlachou, Maria, Matthaios Didagelos, Antonios Kouparanis, Haralambos Karvounis, and Antonios Ziakas. "Bridging with Tirofiban During Temporary Withdrawal of Oral Antiplatelets for Two Major Surgical Procedures in High Ischaemic Risk Patients." Open Cardiovascular Medicine Journal 13, no. 1 (February 15, 2019): 1–4. http://dx.doi.org/10.2174/1874192401913010001.
Full textChua, Su-Kiat, Lung-Ching Chen, Kou-Gi Shyu, Jun-Jack Cheng, Huei-Fong Hung, Chiung-Zuan Chiu, and Chiu-Mei Lin. "Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials." Journal of Clinical Medicine 9, no. 4 (April 8, 2020): 1062. http://dx.doi.org/10.3390/jcm9041062.
Full textLupercio, Florentino, Shaun Giancaterino, Pedro Arturo Villablanca, Frederick Han, Kurt Hoffmayer, Gordon Ho, Farshad Raissi, et al. "P2Y12 inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis." Heart 106, no. 8 (February 7, 2020): 575–83. http://dx.doi.org/10.1136/heartjnl-2019-315963.
Full textDissertations / Theses on the topic "Oral P2Y12 inhibitor"
Khan, Nazish. "The clinical efficacy of oral P2Y12 inhibitor antiplatelet therapies during an acute myocardial infarction in patients undergoing percutaneous coronary intervention." Thesis, University of Birmingham, 2017. http://etheses.bham.ac.uk//id/eprint/7315/.
Full textBooks on the topic "Oral P2Y12 inhibitor"
Valgimigli, Marco, and Marco Angelillis. Treatment of non-ST elevation acute coronary syndromes. Edited by Stefan James. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198784906.003.0311.
Full textBook chapters on the topic "Oral P2Y12 inhibitor"
"Direct oral P2Y12 inhibition: AZD6140 (Ticagrelor)." In Clinical Guide to the Use of Antithrombotic Drugs in Coronary Artery Disease, 113–18. CRC Press, 2008. http://dx.doi.org/10.3109/9780203091494-18.
Full textBecker, Richard C., and Frederick A. Spencer. "Clopidogrel." In Fibrinolytic and Antithrombotic Therapy. Oxford University Press, 2006. http://dx.doi.org/10.1093/oso/9780195155648.003.0013.
Full textConference papers on the topic "Oral P2Y12 inhibitor"
Khan, Nazish, Joe Martins, Ben Wrigley, Saib Khogali, Shahzad Munir, Andrew Smallwood, Peter Nightingale, and James Cotton. "11 Oral P2Y12 inhibitors and stemi outcomes: a single centre propensity scored analysis." In British Cardiovascular Society Annual Conference ‘High Performing Teams’, 4–6 June 2018, Manchester, UK. BMJ Publishing Group Ltd and British Cardiovascular Society, 2018. http://dx.doi.org/10.1136/heartjnl-2018-bcs.11.
Full text